Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies-Reference-Cited by-同舟云学术

Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies

Published:2018-11 Issue: Volume:116 Page:58-66
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Langdahl Bente L.,Silverman Stuart,Fujiwara Saeko,Saag Ken,Napoli Nicola,Soen Satoshi,Enomoto Hiroyuki,Melby Thomas E.,Disch Damon P.,Marin Fernando,Krege John H.

Funder

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis;Neer;N. Engl. J. Med.,2001

2. The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures;Hadji;Osteoporos. Int.,2012

3. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial;Kendler;Lancet,2017

4. Teriparatide or alendronate in glucocorticoid-induced osteoporosis;Saag;N. Engl. J. Med.,2007

5. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS);Langdahl;Calcif. Tissue Int.,2009

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of new fractures in older patients with osteoporosis receiving biosimilar teriparatide or reference products: A retrospective cohort study;British Journal of Clinical Pharmacology;2024-09-08

2. Bone Fragility in Diabetes and its Management: A Narrative Review;Drugs;2024-08-05

3. Delivery of A Jagged1-PEG-MAL hydrogel with Pediatric Human Bone Cells Regenerates Critically-Sized Craniofacial Bone Defects;2024-07-19

4. Delivery of A Jagged1-PEG-MAL hydrogel with Pediatric Human Bone Cells Regenerates Critically-Sized Craniofacial Bone Defects;2024-07-19

5. Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?;European Journal of Endocrinology;2024-06-28